Profound Medical Valuation
| PROF Stock | USD 8.21 0.48 6.21% |
At this time, the company appears to be undervalued. Profound Medical Corp holds a recent Real Value of $10.46 per share. The prevailing price of the company is $8.21. Our model determines the value of Profound Medical Corp from analyzing the company fundamentals such as Return On Equity of -1.24, shares outstanding of 36.29 M, and Operating Margin of (1.69) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Profound Medical's valuation include:
Price Book 8.7732 | Enterprise Value | Enterprise Value Ebitda (5.75) | Price Sales 19.6226 | Enterprise Value Revenue 18.2696 |
Undervalued
Today
Please note that Profound Medical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Profound Medical Corp is based on 3 months time horizon. Increasing Profound Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Profound stock is determined by what a typical buyer is willing to pay for full or partial control of Profound Medical Corp. Since Profound Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Profound Stock. However, Profound Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.21 | Real 10.46 | Target 12.1 | Hype 8.2 |
The real value of Profound Stock, also known as its intrinsic value, is the underlying worth of Profound Medical Corp Company, which is reflected in its stock price. It is based on Profound Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Profound Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Profound Medical Corp helps investors to forecast how Profound stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Profound Medical more accurately as focusing exclusively on Profound Medical's fundamentals will not take into account other important factors: When choosing an evaluation method for Profound Medical Corp, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Profound Medical Cash |
|
Profound Revenue by Product
Profound Medical Total Value Analysis
Profound Medical Corp is at this time estimated to have valuation of 261.2 M with market capitalization of 280.54 M, debt of 5.12 M, and cash on hands of 46.21 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Profound Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
261.2 M | 280.54 M | 5.12 M | 46.21 M |
Profound Medical Investor Information
About 35.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.32. Profound Medical Corp last dividend was issued on the 16th of October 2019. The entity had 1:10 split on the 16th of October 2019. Profound Medical Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Profound Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Profound Medical has an asset utilization ratio of 14.48 percent. This implies that the Company is making $0.14 for each dollar of assets. An increasing asset utilization means that Profound Medical Corp is more efficient with each dollar of assets it utilizes for everyday operations.Profound Medical Ownership Allocation
Profound Medical owns a total of 36.29 Million outstanding shares. 30% of Profound Medical Corp outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. On August 26, 2021, Representative Tom Malinowski of US Congress acquired under $15k worth of Profound Medical Corp's common stock.Profound Medical Profitability Analysis
The company reported the previous year's revenue of 10.17 M. Net Loss for the year was (27.82 M) with profit before overhead, payroll, taxes, and interest of 10.36 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Profound Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Profound Medical and how it compares across the competition.
About Profound Medical Valuation
The stock valuation mechanism determines Profound Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Profound Medical. We calculate exposure to Profound Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Profound Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 7.7 M | 8.1 M | |
| Pretax Profit Margin | (2.34) | (2.46) | |
| Operating Profit Margin | (2.79) | (2.93) | |
| Net Loss | (2.34) | (2.46) | |
| Gross Profit Margin | 0.59 | 0.39 |
Profound Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of Profound Medical Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Profound we look at many different elements of the entity such as Profound's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Profound Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Profound Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Profound Medical's worth.Complementary Tools for Profound Stock analysis
When running Profound Medical's price analysis, check to measure Profound Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profound Medical is operating at the current time. Most of Profound Medical's value examination focuses on studying past and present price action to predict the probability of Profound Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profound Medical's price. Additionally, you may evaluate how the addition of Profound Medical to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |